@article{18383,
  keywords = {Adult, Aged, Aged, 80 and over, Clofazimine, Dapsone, Drug Therapy, Combination, Female, Humans, Leprostatic Agents, leprosy, Male, Middle Aged, Rifampin},
  author = {Lim J T and Tan T},
  title = {Efficacy and safety of multidrug therapy in paucibacillary leprosy in Singapore.},
  abstract = {<p>A total of 49 patients with paucibacillary leprosy (PB) who completed multidrug therapy (MDT) between 1985 and 1990 were analysed retrospectively for efficacy and complications; 20 (40.8%) patients had borderline-tuberculoid (BT), 13 (26.5%) had tuberculoid (TT), 1 (2.1%) had indeterminate (I) and 15 (30.0%) had pure neural (N) leprosy; 26 patients (76.5% of 34 non-neural leprosy) were skin biopsied for histological cure before MDT was stopped. Of these 26 patients, 19 had histological clearance at 6 months while the remaining 7 cleared beyond 1 year (18-36 months). The remaining 8 non-neural patients who refused rebiopsy had MDT for 6-8 months and the MDT was stopped when there was clinical clearance. Of the 15 neural (N) leprosy patients, 11 were given MDT for 6 months while the rest had 12-18 months of treatment; 1 patient with neural leprosy, who was treated for 6 months, relapsed with BT leprosy 18 months post-treatment. There were few complications among the 49 patients-4 (8.2%) patients developed reaction to dapsone, 1 (2.0%) had the dapsone syndrome, 2 (4.1%) had haemolytic anaemia and 1 (2.0%) had dapsone hepatitis; 7 (14.3%) patients had type I reaction.</p>},
  year = {1993},
  journal = {Leprosy review},
  volume = {64},
  pages = {136-42},
  month = {1993 Jun},
  issn = {0305-7518},
  url = {http://leprev.ilsl.br/pdfs/1993/v64n2/pdf/v64n2a07.pdf},
  doi = {10.5935/0305-7518.19930016},
  language = {eng},
}